Clinical trial • Phase III • Neurology
Clinical trial in Stroke
Phase III trial for Stroke. 60 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Stroke
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 11-10-2024
- First CTIS Authorization Date
- 21-11-2024
Trial design
Phase III trial across 1 site in Netherlands.
- Target Sample Size
- 60
Recruitment
- Planned Sample Size
- 60
- Recruitment Window Months
- 43
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 60
Netherlands
- Earliest CTIS Part Ii Submission Date
- 24-09-2024
- Latest Decision Or Authorization Date
- 21-11-2024
- Processing Time Days
- 58
- Number Of Sites
- 1
- Number Of Participants
- 60
Sites
- Site Name
- Centre for Human Drug Research
- Department Name
- n.a.
- Contact Person Name
- G. Jacobs
- Contact Person Email
- clintrials@chdr.nl
Sponsor
Primary sponsor
- Full Name
- Algernon Pharmaceuticals Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Canada
Related trials
Other published trials that may interest you.